Kobayashi Pharmaceutical Co Ltd (4967)

Currency in JPY
5,430.0
+3.0(+0.06%)
Closed·
4967 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4967 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5,380.05,450.0
52 wk Range
4,850.06,350.0
Key Statistics
Bid/Ask
5,425.00 / 5,444.00
Prev. Close
5,427
Open
5,429
Day's Range
5,380-5,450
52 wk Range
4,850-6,350
Volume
132.4K
Average Volume (3m)
258.04K
1-Year Change
1.2%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4967 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5,567.5
Upside
+2.53%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 8 consecutive years
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Kobayashi Pharmaceutical Co Ltd Company Profile

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, cooling gel sheets, and oral hygiene products. It also manufactures and sells pharmaceuticals, cosmetics, and health foods; and manufactures and sells synthetic resin products; markets nutritional supplements and skin care products through mail orders; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers. In addition, the company engages in transportation, real estate management, and advertising planning and production businesses; manufacture of sanitary and paper products; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

Compare 4967 to Peers and Sector

Metrics to compare
4967
Peers
Sector
Relationship
P/E Ratio
34.2x22.8x12.1x
PEG Ratio
−2.360.440.03
Price/Book
1.9x1.7x1.5x
Price / LTM Sales
2.5x1.5x0.9x
Upside (Analyst Target)
−0.2%0.3%16.8%
Fair Value Upside
Unlock15.3%11.0%Unlock

Analyst Ratings

2 Buy
6 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 5,567.5
(+2.53% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 158.71%
Dividend Yield
1.92%
Industry Median 2.15%
Annualised payout
104.00
Paid unevenly
5-Years Growth
+6.84%
Growth Streak

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
20.75 / 25.43
Revenue / Forecast
36.41B / 38.27B
EPS Revisions
Last 90 days

4967 Income Statement

People Also Watch

2,374.0
8306
+6.01%
21,505.0
8035
+1.18%
163.0
9432
+0.62%
6,628.0
4452
-0.67%

FAQ

What Stock Exchange Does Kobayashi Pharmaceutical Trade On?

Kobayashi Pharmaceutical is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Kobayashi Pharmaceutical?

The stock symbol for Kobayashi Pharmaceutical is "4967."

What Is the Kobayashi Pharmaceutical Market Cap?

As of today, Kobayashi Pharmaceutical market cap is 403.59B.

What Is Kobayashi Pharmaceutical's Earnings Per Share (TTM)?

The Kobayashi Pharmaceutical EPS (TTM) is 158.71.

When Is the Next Kobayashi Pharmaceutical Earnings Date?

Kobayashi Pharmaceutical will release its next earnings report on 03 Nov 2025.

From a Technical Analysis Perspective, Is 4967 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Kobayashi Pharmaceutical Stock Split?

Kobayashi Pharmaceutical has split 3 times.

How Many Employees Does Kobayashi Pharmaceutical Have?

Kobayashi Pharmaceutical has 3615 employees.

What is the current trading status of Kobayashi Pharmaceutical (4967)?

As of 15 Aug 2025, Kobayashi Pharmaceutical (4967) is trading at a price of 5,430.00, with a previous close of 5,427.00. The stock has fluctuated within a day range of 5,380.00 to 5,450.00, while its 52-week range spans from 4,850.00 to 6,350.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.